The Babraham Institute receives strategic funding from the BBSRC
The Babraham Institute receives strategic funding from the BBSRC
The Institute
Director's welcome
Research
Governance
Partnerships
Transparency of Spend
Social Responsibility
Research into Action
Knowledge Exchange
Translation Activities
The Organisation
Institute Organogram
Science Organisation
Administration
Press Office
Institute Life
Environment
Nursery
Housing
Sports & Social Club
Catering on site
Local Amenities
Institute Publications
How to find us
Disclaimer
13 new collaborative research projects, involving 11 different companies
12 new PhD Studentship Collaborative Awards in Science & Engineering (CASE) initiated, to be hosted at the Institute and involving 8 different partner companies
20 new consultancies started, in which Institute staff advised 14 different companies. In addition, 6 existing consultancies with 5 companies were renewed
7 licences to the Institute’s Intellectual Property Rights signed
Crescendo Biologics Ltd was spun-out of the Institute in 2007. The company raised £4.5 million in seed funding in 2009, and in 2010 announced the generation of the first “triple-knockout” mouse. Crescendo Biologics is based on the Babraham Research Campus, and continues to collaborate with Institute scientists
58 companies and other external organisations benefitted from access to the Institute’s scientific facilities and services
The Institute makes available mouse lines, antibodies and other reagents to academic organisations under material transfer agreements. In addition the Institute’s Antibody Facility sells antibodies generated by the Institute, and in this period provided these to 110 external organisations.
Babraham Institute - Babraham Research Campus - Cambridge - United Kingdom